AT309795T - Acetylcholinesterase inhibitors for the treatment and diagnosis of respiratory disorders of sleep during - Google Patents

Acetylcholinesterase inhibitors for the treatment and diagnosis of respiratory disorders of sleep during

Info

Publication number
AT309795T
AT309795T AT96943443T AT96943443T AT309795T AT 309795 T AT309795 T AT 309795T AT 96943443 T AT96943443 T AT 96943443T AT 96943443 T AT96943443 T AT 96943443T AT 309795 T AT309795 T AT 309795T
Authority
AT
Austria
Prior art keywords
diagnosis
treatment
respiratory disorders
acetylcholinesterase inhibitors
sleep during
Prior art date
Application number
AT96943443T
Other languages
German (de)
Inventor
Jan Hedner
Original Assignee
Curapath Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE9504537A priority Critical patent/SE9504537D0/en
Application filed by Curapath Ab filed Critical Curapath Ab
Priority to PCT/SE1996/001677 priority patent/WO1997022339A1/en
Publication of AT309795T publication Critical patent/AT309795T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
AT96943443T 1995-12-19 1996-12-17 Acetylcholinesterase inhibitors for the treatment and diagnosis of respiratory disorders of sleep during AT309795T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9504537A SE9504537D0 (en) 1995-12-19 1995-12-19 Ways to treat and diagnose breathing disorders during sleep and means of carrying out the process
PCT/SE1996/001677 WO1997022339A1 (en) 1995-12-19 1996-12-17 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method

Publications (1)

Publication Number Publication Date
AT309795T true AT309795T (en) 2005-12-15

Family

ID=20400641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943443T AT309795T (en) 1995-12-19 1996-12-17 Acetylcholinesterase inhibitors for the treatment and diagnosis of respiratory disorders of sleep during

Country Status (11)

Country Link
US (1) US6034117A (en)
EP (1) EP0923370B1 (en)
JP (1) JP3756193B2 (en)
AT (1) AT309795T (en)
AU (1) AU701911B2 (en)
CA (1) CA2240717C (en)
DE (2) DE69635459T2 (en)
DK (1) DK0923370T3 (en)
ES (1) ES2256865T3 (en)
SE (1) SE9504537D0 (en)
WO (1) WO1997022339A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030667B1 (en) * 1997-11-14 2005-03-02 Akzo Nobel N.V. Use of mirtazapine for the manufacture of a medicament for treating sleep apneas
US6352715B1 (en) * 1998-02-19 2002-03-05 Sagittarius Life Science Corp Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease
US6262081B1 (en) 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
DE19856897A1 (en) * 1998-12-10 2000-06-15 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh A therapeutic agent for suppressing snoring noises
CN100370990C (en) * 1998-12-24 2008-02-27 詹森药业有限公司 Controlled release galantamine composition
DE10004790B4 (en) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible
US20070173893A1 (en) * 2000-10-20 2007-07-26 Pitts Walter C Method and apparatus for preventing obstructive sleep apnea
FR2820423B1 (en) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate and phosphate 3,4-diaminopyridine, pharmaceutical compositions and uses
CN1194688C (en) * 2001-07-03 2005-03-30 山东绿叶制药股份有限公司 Slow releasing microspheres of transcutaneous huperzine A and its derivative or salt for injection and its preparing process
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
AU2003287433A1 (en) * 2002-11-01 2004-06-07 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
US20040266659A1 (en) * 2003-06-27 2004-12-30 Stephen LaBerge Substances that enhance recall and lucidity during dreaming
CA2535613A1 (en) 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Treatment of sleep disorders with cholinesterase inhibitors
KR20070085033A (en) 2003-10-21 2007-08-27 코루시드 파마슈티컬즈 인코포레이티드 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
DE10354894A1 (en) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Oral formulations of deoxypeganine and their applications
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
AU2008214380A1 (en) 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
CA2693110A1 (en) * 2007-07-18 2009-01-22 Colucid Pharmaceuticals, Inc. Methods for promoting wakefulness
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
CA2825309A1 (en) 2011-01-28 2012-08-02 Pfantastic Medical Research Institute, Llc Pyridostigmine for the treatment of obstructive sleep apnea
US9642841B1 (en) * 2014-03-14 2017-05-09 James M. Hand Snoring treatment
JP6526475B2 (en) * 2015-04-30 2019-06-05 サンスター株式会社 Salivary secretion promoter for transdermal salivary gland administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
DE4115558C2 (en) * 1991-05-13 1993-07-08 Arzneimittelwerk Dresden Gmbh, O-8122 Radebeul, De
AT183084T (en) * 1991-05-14 1999-08-15 Ernir Snorrason Treatment of fatigue syndrome with cholinesterase inhibitors
DE19548812A1 (en) * 1995-12-27 1997-07-03 Hoechst Ag Use of inhibitors of the cellular Na + · · / · H + · -Exchangers (NHE) for the manufacture of a medicament for respiratory stimulation

Also Published As

Publication number Publication date
CA2240717A1 (en) 1997-06-26
EP0923370A2 (en) 1999-06-23
JP2000511873A (en) 2000-09-12
ES2256865T3 (en) 2006-07-16
AU1217697A (en) 1997-07-14
EP0923370B1 (en) 2005-11-16
SE9504537D0 (en) 1995-12-19
US6034117A (en) 2000-03-07
WO1997022339A1 (en) 1997-06-26
DE69635459T2 (en) 2006-08-03
CA2240717C (en) 2002-11-26
JP3756193B2 (en) 2006-03-15
DE69635459D1 (en) 2005-12-22
DK0923370T3 (en) 2006-03-27
AU701911B2 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
DE69625906D1 (en) Dinucleotides for use in the treatment of lung diseases
DE69229499T2 (en) Device for nerve irritation for treatment of disorders of alimentärfunktion
DE69527903D1 (en) A device for treatment of obstructive apnea in sleep
DE69617047D1 (en) An arrangement for treatment of the skin
DE69333658D1 (en) A method for the treatment of organs and tissue
DE69932984D1 (en) System and treatment for the suppression of Sepsis
DE69535234D1 (en) Means for treatment of allergic rhinitis and other diseases comprising descarboethoxyloratadine
DE69726245D1 (en) Humidifying device for the treatment of apnea in sleep
DE69332641T2 (en) Anabaseine derivatives for the treatment of degenerative diseases of the nervous system
DE69514257T2 (en) Implant for the treatment of fractures of the femur
DE69729473D1 (en) Pharmaceutical-genetic methods for use in the treatment of diseases of the nervous system
DE69625690D1 (en) A process for the prevention and treatment of allergies
DE69838719D1 (en) organize and apparatus for coordinating the combined use of topical aerosols in the treatment of respiratory diseases
DE69609868T2 (en) New steroidester for treatment of skin diseases
DE69926731D1 (en) Diagnosis and treatment of aur1 and / or related diseases aur2
DE69734284D1 (en) Composition of a polynukleotidvakzins for the treatment of respiratory and related diseases of the pig reproduction
AT552006T (en) Use of a neurotoxin therapy for the treatment of urological and associated diseases
DE69518729T2 (en) Nitric oxide-donating compound for the treatment of anal diseases
DE69511181T2 (en) Agents for the treatment of hepatobiliary diseases
DE69826550D1 (en) Device for non-invasive treatment of biological tissue
AT132747T (en) Sprays for treatment of infections of the tract respiratorius
AT334668T (en) A pharmaceutical composition for the treatment of neurological and neuropsychiatric disorders
DE69526728T2 (en) USE OF IL-12 AND IL-12 antagonist for the manufacture of a medicament FOR TREATMENT OF AUTOIMMUNE DISEASE
DE69715611D1 (en) Using a rapamycinderivates for treatment of vascular diseases and xenotransplantation
DE69720463T2 (en) Sulfonamide derivatives and their use for the treatment of CNS disorders

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 0923370

Country of ref document: EP

REN Ceased due to non-payment of the annual fee